Commercialization: Page 58
-
PharmaVoice Team/PharmaVoice
Letter from the Editor
Volume 12 • Number 10 Publisher Lisa Banket Editor Taren Grom Creative Director Marah Walsh Managing Editor Denise Myshko Senior Editor Robin Features Editor Kim Ribbink Contributing Editor Carolyn Gretton Design Associate Ariel Medel National Account Managers Trish Kane, Cathy Tracy WEBCAST?NETW...
By Taren Grom • Nov. 8, 2012 -
PharmaVoice Team/PharmaVoice
Segmentation and Personalization Brings Targets into Focus
With the tools that are available today, the industry can hone in on the right targets. Sophisticated technology and a more diverse field of targets are creating a new segmentation model that moves away from the practice of solely monitoring prescribing behaviors. The new environment requires str...
By Robin Robinson • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
A Changing Mindset: Managing Managed Markets
The industry must revamp its managed markets strategies from the ground up to survive in the new reality of value propositions. Since the onset of healthcare reform, the role and power of payers have been growing steadily and has reached a point of painful reality for the industry. Starting today...
By PharmaVoice Team • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
Industry Spotlight: The Man, the Molecule, the Market: Untangling Alzheimer's Mystery
Alzheimer’s disease is a progressive brain disorder that damages and eventually destroys brain cells, leading to loss of memory, thinking, and other brain functions. Alzheimer’s is not a part of normal aging, but results from a complex pattern of abnormal changes. It usually develops slowly and g...
By PharmaVoice Team • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical Pool Dr. Lawrence Bloch Infinity Names Business Chief Lawrence Bloch, M.D., has joined Infinity Pharmaceuticals as executive VP, chief financial officer, and chief business officer. Dr. Bloch is responsible for the company’s corporate, financial, and business development strategies...
By Carolyn Gretton • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, marketing, And R&D?Trends affecting the healthcare industry Oncologists Rate Genentech Highest in Image Trend: Analysts correlate overall company image with key behaviors such as recommending products to colleagues, providing additional time for sales reps and medical science liaisons,...
By PharmaVoice Team • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
Social Media
Social Media Innovators Move Beyond Corporate Facebook Pages Trend: More digital channels, more diversity, more ways to reach consumers GSK Leverages Olympic Sponsorship Through Digital Media This summer, GlaxoSmithKline provided the official laboratory services for the London 2012 Olympic and Pa...
By Robin Robinson • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New electronic and web-based applications, sites, and technologies Physicians Interactive Unveils Zero-Click eCoupon Solution Trend: As more healthcare practitioners (HCPs) employ electronic prescription systems, they are looking for ways to build cost savings and adherence incentives into the wo...
By Carolyn Gretton • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
What's New
DIA and HBA Collaborate on Women’s Leadership Project Trend: The associations’ career-building initiative focuses on regulatory, medical, legal, and compliance functions within the life-sciences industry. The DIA/HBA Leadership Project is a multiyear initiative launched by DIA and the Healthcare ...
By Carolyn Gretton • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
UpFront
Awards… Amylin’s Diabetes Product Honored Amylin’s Bydureon has been honored by the Distribution Management Awards for Notable Achievements in Healthcare (DIANA) for the category of best new pharmaceutical product introduction. The DIANA award recognizes pharmaceutical and consumer product manufa...
By Taren Grom • Sept. 27, 2012 -
PharmaVoice Team/PharmaVoice
Are We Paying Attention to the Right Conversation?
Al Topin, President Conversation, beyond a doubt, is the marketing buzzword of the last couple of years. Listen to the conversation. Be part of the conversation. Make sure your brand isn’t left out of the conversation. Patients on Facebook. Caregivers on YouTube. Healthcare practitioners on Sermo...
By Al Topin • Aug. 31, 2012 -
PharmaVoice Team/PharmaVoice
Understanding the Information Needs of Today's Healthcare Decision-Maker
Understanding the Information Needs of Today’s Healthcare Decision-Maker Women make 80% of healthcare decisions. New research provides insights on the best ways to engage them. According to recent articles in TIME magazine and Harvard Business Review, as well as a host of studies and books, the e...
By Amy Krane • Aug. 31, 2012 -
PharmaVoice Team/PharmaVoice
The Musing of an Ad Guy: It's All Part of the Thrill
It’s a tough world out there. And advertising is no exception. Complex strategies, audience segmentation, targeted creative concepts, and the expression of these ideas across the digital world make our tasks very challenging. Add to that the time and financial pressures that impact us all and you...
By John Nosta • Aug. 31, 2012 -
PharmaVoice Team/PharmaVoice
Thrilling Clients?
In today’s pharma world of patent expirations, consolidations, downsizing, and shrinking budgets, we are finding that having “happy and satisfied" clients is no longer good enough. Today’s environment demands that agencies strive to build team chemistry, deepen relationships, and seek to “thrill ...
By Peter Rooney • Aug. 31, 2012 -
PharmaVoice Team/PharmaVoice
Direct to the ePharma Consumer in the Age of Connectivity
Direct to the ePharma Consumer — In the Age of Connectivity It is not a passing fad but a permanent shift. E-pharma consumers are here to stay, requiring pharmaceutical and medical device companies to adapt to the new digital environment. However, to understand the hesitancy of the pharma industr...
By Liz Moench • Aug. 31, 2012 -
PharmaVoice Team/PharmaVoice
Why Getting A Foot In the Door These Days Doesn't Involve a Foot…or even a person
Jeff Meehan, Chief Commercial Officer, MD On-line MD On-Line Inc. is a leading provider of electronic data interchange (EDI) solutions that facilitate the critical connection between doctors and payers. For more information visit mdon-line.com. { For more information about Instinctive Data, cal...
By Jeff Meehan • Aug. 31, 2012 -
PharmaVoice Team/PharmaVoice
PR Can Help Brand Planners Do More With Less
Jeff Hoyak, President, MCS Healthcare Public Relations MCS Healthcare Public Relations is an independent, award-winning global communications agency, which has provided its clients with creativity, service and results since 1985. { For more information, visit mcspr.com. creative PRApharma prod...
By Jeff Hoyak • Aug. 31, 2012 -
PharmaVoice Team/PharmaVoice
Increasing Valuation by Early Integration of Identity Development Into Commercialization
At most life-sciences investment conferences, you’ll often see a brilliant biochemist in a darkened auditorium enthusiastically presenting his company’s new molecule. His scientist-to-scientist talk, peppered with pathways, establishes him clearly to be a top thinker in his field. His PowerPoint ...
By Camille Desantics • Aug. 31, 2012 -
PharmaVoice Team/PharmaVoice
Can We Make Non-personal Promotion Feel More Personal?
Can We Make Non-personal Promotion Feel More Personal? Personal promotion — which for years was defined as a physician office visit — is in danger of becoming extinct. I liken the evolution of pharma’s rep-focused selling model to a Tyrannosaurus rex: once massive in size, initially considered to...
By Ken Ribotsky • Aug. 31, 2012 -
PharmaVoice Team/PharmaVoice
The Era of Transparency
Now that the Supreme Court has upheld the constitutionality of the Affordable Care Act, pharmaceutical companies must continue to move forward to implement the provisions in the law. One such provision is the Physician Payment Sunshine Act, which requires manufacturers of pharmaceuticals and medi...
By Denise Myshko • Aug. 30, 2012 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Dr. Dipak PANIGRAHI Silvia TAYLOR Sucampo Names Executives Global pharmaceutical firm Sucampo Pharmaceuticals has added two VPs to its leadership team. Sucampo has appointed Dipak Panigrahi, M.D., VP, medical affairs. Dr. Panigrahi’s responsibilities include establishing and l...
By Carolyn Gretton • Aug. 30, 2012 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Compliance Programs Make Room for Integrity Agreements Use of PROs in Product Evaluations on the Rise Other market insights… Patent Cliff Hits Global Pharma Market Growth Declining R&D Budgets Drive Drug Discovery Ou...
By Carolyn Gretton • Aug. 30, 2012 -
PharmaVoice Team/PharmaVoice
Social Media
Social Media Social Media Trends, Regs, and Apps Featured Briefs: Janssen Healthcare Innovation Develops Mobile Medication Reminder Platformfs: Janssen’s Mobile Adherence Platform is Product Agnostic Sermo Beefs Up Interactive Health Education Centers Txt4Health spreads diabetes awareness in New ...
By Robin Robinson • Aug. 30, 2012 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: OpenQ SafeGuard Manages Social Enterprise Compliance Risk System Aims to Reduce Research Cycle Times In other technology news… E-UPGRADES AND ENHANCEMENTS Site Offers New Way for Life-Sciences Firms to Find Partn...
By Carolyn Gretton • Aug. 30, 2012 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies Featured Briefs: Core-Create Merges with Brandkarma CST Supports Established Pharmaceutical, OTC Brands In other news… HHS Creates New Centers for Medical Countermeasures AROUND THE GLOBE The Core Nation’s healthcare marketing communicatio...
By Carolyn Gretton • Aug. 30, 2012
Previous
